The DNA damage induced immune response: Implications for cancer therapy

Eliana M Barros1, Stuart A McIntosh1, Kienan I Savage1

  • 1Patrick G Johnston Centre for Cancer Research & Cell Biology, Queen's University Belfast, 97 Lisburn Rd, Belfast BT9 7AE, UK.

DNA Repair
|October 29, 2022
PubMed

Insights

Defects in DNA damage response (DDR) pathways can activate the cGAS/STING innate immune pathway, influencing cancer development and treatment. This interplay offers new therapeutic strategies combining DNA damage agents with immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Genomic instability is a key feature of cancer, impacting tumor progression and treatment outcomes.
  • Deficiencies in DNA damage response (DDR) pathways are increasingly recognized for their role in shaping therapeutic responses, particularly with immune checkpoint blockade (ICB) therapy.
  • The cGAS/STING signaling pathway is a critical mediator of inflammation in response to DNA damage.

Approach:

  • Transcriptional profiling of BRCA1/2 deficient breast cancers and Fanconi Anaemia (FA) patient bone marrow identified a common subgroup with upregulated innate immune signaling.
  • The study reviews the literature on intrinsic and extrinsic DNA damage in mediating immune activation.
  • The review explores the context of DNA damage-induced immune responses within tumorigenesis.

Key Points:

  • DNA damage response defects, such as those in BRCA1/2 and FA, are linked to the activation of innate immune signaling via the cGAS/STING pathway.
  • DNA damage, whether from inherent repair defects or external agents like chemotherapy and radiation, can trigger an innate immune response.
  • This immune activation presents potential therapeutic opportunities in cancer treatment.

Conclusions:

  • The interplay between DNA damage response pathways and the immune system, particularly via cGAS/STING, is crucial in cancer.
  • Understanding this connection opens avenues for novel cancer therapies, including the combination of DNA damaging agents with immunotherapies.

Related Concept Videos

Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
31.4K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.7K